Fixed drug eruption in a cribriform pattern: an atypical presentation. [PDF]
Mathur M +5 more
europepmc +1 more source
Just the facts: diagnosis and management of Stevens-Johnson syndrome/toxic epidermal necrolysis. [PDF]
Yeung J, Dytoc M, Mutter E, Dutz JP.
europepmc +1 more source
Clinical cues for distinguishing bullous fixed drug eruption from Stevens-Johnson syndrome: A case report. [PDF]
Samman L +3 more
europepmc +1 more source
Low-dose venlafaxine-induced erythema multiforme: a case report. [PDF]
Rezapour M, Mesgarankarimi A.
europepmc +1 more source
Accurately describing drug allergies and adverse drug reactions: The Australian Delphi Consensus on Drug Allergy Terminology. [PDF]
Kehoe J +9 more
europepmc +1 more source
Chemical Motifs Associated with FAERS-Derived Severe Cutaneous Adverse Reaction Disproportionality Signals: An Interpretable Pharmacovigilance-Driven Cheminformatics Study. [PDF]
Uesawa Y, Inden K, Asada M.
europepmc +1 more source
Enfortumab vedotin therapy complicated by bullous dermatitis: A case report. [PDF]
Hojjatie RA +4 more
europepmc +1 more source
Risk of drug eruption associated with the use of tetracyclines, macrolides, and fluoroquinolones: real-world evidence from a pharmacovigilance study utilizing the FDA adverse event reporting system. [PDF]
Alshammari TM.
europepmc +1 more source
A review on toxic epidermal necrolysis-like superficial wound lesions: Issue and challenge on 10 clinical entities. [PDF]
Abtahi-Naeini B +3 more
europepmc +1 more source

